Aspira Women's Health (AWH) Peer Comparison

$0.08

$0.00 (-4.39%)

As on 16-May-2025 09:30EDT

Market cap

$3 Mln

Revenue (TTM)

$7 Mln

P/E Ratio

--

P/B Ratio

5

Div. Yield

0 %

Edit

	Aspira Women's Health (AWH)	Crispr Therapeutics AG (CRSP)	AC Immune SA - ADR	Adc Therapeutics SA (ADCT)
Market cap ($ Mln)	3	5,244	251	135
Revenue ($ Mln)	7	13	18	79
Net Profit ($ Mln)	-8.47	-451.14	-43.16	-96.91
Net Margin (%)	-120.43	-3,368.72	-246.49	-123.03
RoE (%)	--	-24.60	-107.75	--
Price to Earnings	--	--	--	--
Price-To-Book	5.02	3.09	6.57	3.42

Cashflow
Ratios

Cashflow ($ Mln)

	Aspira Women's Health (AWH)	Crispr Therapeutics AG (CRSP)	AC Immune SA - ADR	Adc Therapeutics SA (ADCT)
Cash From Operating Activities	-12.11	-142.77	65.84	-123.84
Cash Flow from Investing Activities	--	-280.48	-105.29	-0.87
Cash from Financing Activities	11.06	331.98	-1.12	97.05
Net Cash Inflow / Outflow	--	--	--	--

Ratios

Profitability Ratios

	Aspira Women's Health (AWH)	Crispr Therapeutics AG (CRSP)	AC Immune SA - ADR	Adc Therapeutics SA (ADCT)
ROCE (%)	-3,817.49	-17.13	-36.13	304.97
ROE (%)	531.41	-19.20	-37.31	89.97
ROA (%)	-75.78	-16.38	-24.61	-46.65
EBIT Margin (%)	-181.42	--	--	--
Net Margin (%)	-120.43	-1,046.43	-186.44	-222.83
Cash Profit Margin (%)	0.00	--	--	--

Growth Ratios

	Aspira Women's Health (AWH)	Crispr Therapeutics AG (CRSP)	AC Immune SA - ADR	Adc Therapeutics SA (ADCT)
Revenue Growth (%)	-21.82	-0.91	0.85	0.02
EBIT Growth (%)	3.05	--	--	--
Net Profit Growth (%)	42.58	-138.43	6.12	34.25
EPS Growth (%)	--	-1.27	0.22	0.49
Book Value Growth (%)	--	--	--	--

Valuation Ratios

	Aspira Women's Health (AWH)	Crispr Therapeutics AG (CRSP)	AC Immune SA - ADR	Adc Therapeutics SA (ADCT)
Price / Earnings	--	-9.18	-5.35	-1.33
Price / Book Value	--	1.74	2.43	-1.04
Dividend Yield (%)	--	--	--	--
EV/EBITDA	-0.06	-4.90	-2.31	-0.80
Market Cap ($ Cr)	--	--	--	--

Solvency Ratios

	Aspira Women's Health (AWH)	Crispr Therapeutics AG (CRSP)	AC Immune SA - ADR	Adc Therapeutics SA (ADCT)
Debt to Equity	-0.50	0.12	0.05	-0.61
Short term debt to equity ratio	-0.33	0.01	0.01	-0.01
Current Ratio	0.76	22.07	1.71	3.82
Quick Ratio	0.71	--	9.26	3.59
Interest Coverage	-563.33	--	-381.80	-2.11

Operating Efficiency Ratios

	Aspira Women's Health (AWH)	Crispr Therapeutics AG (CRSP)	AC Immune SA - ADR	Adc Therapeutics SA (ADCT)
Debtors to sales (%)	14.08	71.43	4.02	28.68
Asset Turnover	0.63	0.02	0.13	0.21
Receivable days	48.71	1,174.02	107.97	117.30
Inventory Days	27.27	-31.41	-3.63	1,061.06
Payable days	169.36	87.55	12.66	1,031.41
Cash Conversion Cycle	-93.38	-19.11	91.68	146.95

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly